Literature DB >> 9824780

Gender differences in adverse drug reactions.

C Tran1, S R Knowles, B A Liu, N H Shear.   

Abstract

The objective of this study is to identify gender-related differences in the types of symptoms and drugs reported to cause an adverse drug reaction. Patient data from the Sunnybrook Health Science Centre ADR Clinic for the period from April 1986 to May 1996 were reviewed. Of the 2,367 patients assessed, 74.1% were female. The mean age of the patients was 43 +/- 17 years. Drug classes most frequently reported to elicit an adverse event were general antiinfectives (60.4%), nervous system agents (21.5%), and musculoskeletal agents (3.7%). Skin-related reactions accounted for 49.0% of all reported adverse drug reactions. More than one agent was reported to be responsible for the adverse drug reaction(s) in 50% of the female patients, versus 33.1% of all male patients. Of the female patients, 47.6% were referred for skin or oral challenge testing, versus 41.6% of the male patients. Of the female patients, 6.2% tested positive to the agent compared with 6.1% of all male patients. These results support previous findings that female gender is a risk factor for the development of adverse drug reactions. Further work is required to elucidate the mechanisms explaining the differences observed between male and female patients.

Entities:  

Mesh:

Year:  1998        PMID: 9824780     DOI: 10.1177/009127009803801103

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  51 in total

1.  Rash in psychiatric and nonpsychiatric adolescent patients receiving lamotrigine in Korea: a retrospective cohort study.

Authors:  Hee-Jong Tak; Joon-Ho Ahn; Kun-Woo Kim; Yeni Kim; Sam-Wook Choi; Kyung-Yeon Lee; Eun Jin Park; Soo-Young Bhang
Journal:  Psychiatry Investig       Date:  2012-04-30       Impact factor: 2.505

2.  Effect of a simple dose-escalation schedule on tramadol tolerability : assessment in the clinical setting.

Authors:  I Tagarro; J Herrera; C Barutell; M C Díez; M Marín; D Samper; C Busquet; M J Rodríguez
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

3.  Protocols cure diseases, not patients: flaccid paresis in post-NSTEMI statin treatment.

Authors:  Javier Rosada; Eleni Rebelos; Stefania Petruccelli; Marco Taddei
Journal:  BMJ Case Rep       Date:  2015-04-22

Review 4.  Linking the Epigenome with Exposure Effects and Susceptibility: The Epigenetic Seed and Soil Model.

Authors:  Emma C Bowers; Shaun D McCullough
Journal:  Toxicol Sci       Date:  2016-10-20       Impact factor: 4.849

Review 5.  Drugs and Medical Devices: Adverse Events and the Impact on Women's Health.

Authors:  Jennifer L Carey; Nathalie Nader; Peter R Chai; Stephanie Carreiro; Matthew K Griswold; Katherine L Boyle
Journal:  Clin Ther       Date:  2017-01-07       Impact factor: 3.393

6.  Tissue distribution and gender-divergent expression of 78 cytochrome P450 mRNAs in mice.

Authors:  Helen J Renaud; Julia Yue Cui; Mohammed Khan; Curtis D Klaassen
Journal:  Toxicol Sci       Date:  2011-09-13       Impact factor: 4.849

7.  Risk analysis of severe myelotoxicity with temozolomide: the effects of clinical and genetic factors.

Authors:  Terri S Armstrong; Yumei Cao; Michael E Scheurer; Elizabeth Vera-Bolaños; Rochelle Manning; Mehmet F Okcu; Melissa Bondy; Renke Zhou; Mark R Gilbert
Journal:  Neuro Oncol       Date:  2009-12       Impact factor: 12.300

8.  Sex-dimorphic adverse drug reactions to immune suppressive agents in inflammatory bowel disease.

Authors:  Zuzana Zelinkova; Evelien Bultman; Lauran Vogelaar; Cheima Bouziane; Ernst J Kuipers; C Janneke van der Woude
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

9.  A prospective, observational cohort study to elicit adverse effects of antiretroviral agents in a remote resource-restricted tribal population of Chhattisgarh.

Authors:  Harminder Singh; Navin Dulhani; Pawan Tiwari; Prabhakar Singh; Tiku Sinha
Journal:  Indian J Pharmacol       Date:  2009-10       Impact factor: 1.200

10.  Risk factors associated with adverse drug reactions following hospital admission: a prospective analysis of 907 patients in two German university hospitals.

Authors:  Yurdaguel Zopf; Christina Rabe; Antje Neubert; Eckhart G Hahn; Harald Dormann
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.